All Brochure Flyer

Category

ADC Therapy Antibody Therapy Cell & Gene Therapy Oncolytic Virotherapy Others Protein Therapy Small Molecule Vaccine

Innovation Assets Open for Out-Licensing, Co-Development, or Other Forms of Collaboration

2025/12/10Brochure Antibody Therapy Protein Therapy Oncolytic Virotherapy ...

These innovation assets include antibodies (including mAb, BsAb, and TsAb), ADCs, proteins, and cell and gene therapies.

Out-licensing/Financing: Pioneering mRNA/LNP Delivery Platform-Based in vivo CAR-T Therapy for Autoimmune Diseases

2025/11/13Flyer Cell & Gene Therapy

Based on a pioneering mRNA/LNP delivery platform, an in vivo anti-CD18/BCMA mRNA/LNP CAR-T is being developed for autoimmune diseases.

Out-licensing/Financing: Gene Therapies Based on Revolutionary AAV Vector Technologies

2026/01/10Flyer Cell & Gene Therapy

Dual-AAV vector-based gene therapies are currently undergoing clinical trials for various conditions, including ophthalmic, neuromuscular, and inherited metabolic diseases.